^
Association details:
| Biomarker: | TNFRSF9 overexpression |
|---|---|
| Cancer: | Squamous Cell Carcinoma of Head and Neck |
| Drug Class: | PD1 inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Title:
OC-152 Circulating CD137+ T cells correlate with response to immunotherapy in head and neck cancer patients
Published date:
02/08/2023
Excerpt:
Our results suggest that in R/M HNSCC patients the levels of circulating CD137+T cells could predict the response to immunotherapy and could be used as biomarkers for successful anti-cancer immunotherapy.
